ES2175425T3 - Antibiotico micrococcina para la prevencion y tratamiento de la mastitis. - Google Patents

Antibiotico micrococcina para la prevencion y tratamiento de la mastitis.

Info

Publication number
ES2175425T3
ES2175425T3 ES97929226T ES97929226T ES2175425T3 ES 2175425 T3 ES2175425 T3 ES 2175425T3 ES 97929226 T ES97929226 T ES 97929226T ES 97929226 T ES97929226 T ES 97929226T ES 2175425 T3 ES2175425 T3 ES 2175425T3
Authority
ES
Spain
Prior art keywords
micrococcina
mastitis
treatment
antibiotico
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97929226T
Other languages
English (en)
Spanish (es)
Inventor
Bruno Suri
Catherine Georges
John Edmondson Peel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2175425T3 publication Critical patent/ES2175425T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
ES97929226T 1996-06-20 1997-06-19 Antibiotico micrococcina para la prevencion y tratamiento de la mastitis. Expired - Lifetime ES2175425T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20

Publications (1)

Publication Number Publication Date
ES2175425T3 true ES2175425T3 (es) 2002-11-16

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97929226T Expired - Lifetime ES2175425T3 (es) 1996-06-20 1997-06-19 Antibiotico micrococcina para la prevencion y tratamiento de la mastitis.

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
EP1369425A1 (en) * 2001-03-13 2003-12-10 Yamanouchi Pharmaceutical Co. Ltd. Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN101547698B (zh) * 2006-10-10 2014-01-08 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
JP5773983B2 (ja) 2009-04-08 2015-09-02 ウィスコンシン アルムニ リサーチ ファンデイション 乳房内乳頭シール剤及びその熟成チーズの外観上の欠陥を減少又は除去のための使用
WO2011046853A1 (en) * 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2662300C2 (ru) * 2013-02-08 2018-07-25 Луода Фарма Пти Лимитед Способы лечения микробных инфекций, в том числе мастита
EP2953623B1 (en) * 2013-02-08 2021-06-30 Luoda Pharma Limited Methods of treating topical microbial infections
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
BR112019012804A2 (pt) * 2016-12-27 2020-03-17 Colgate-Palmolive Company Composição antitranspirante/desodorante
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
EP4342484A4 (en) * 2021-05-21 2025-04-16 A&J Science Co.,Ltd. Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169847C (en) * 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis

Also Published As

Publication number Publication date
IL126489A0 (en) 1999-08-17
JP2000513348A (ja) 2000-10-10
AU3341097A (en) 1998-01-07
EP0934075B1 (en) 2002-04-03
PT934075E (pt) 2002-08-30
EP0934075A2 (en) 1999-08-11
DE69711661D1 (de) 2002-05-08
ATE215378T1 (de) 2002-04-15
CN1222081A (zh) 1999-07-07
DE69711661T2 (de) 2002-10-17
BR9709812A (pt) 1999-08-10
AU720243B2 (en) 2000-05-25
DK0934075T3 (da) 2002-06-10
CN1119170C (zh) 2003-08-27
CA2251779A1 (en) 1997-12-24
US6187800B1 (en) 2001-02-13
WO1997048408A3 (en) 1998-02-19
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
ES2175425T3 (es) Antibiotico micrococcina para la prevencion y tratamiento de la mastitis.
ES2074563T3 (es) Procedimiento de preparacion de compuestos y metodo para el tratamiento de la septicemia y/o el choque septico.
MA25009A1 (fr) Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes
AU2003291227A8 (en) Antibacterial agents
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
WO2004058144A3 (en) Antibacterial agents
TW200507841A (en) Antibacterial agents
EP4537828A3 (en) Phospholipid compounds and uses thereof
BR9805032A (pt) Embalagem ventilada de barreira microbiana para dispositivos médicos estéreis e método de embalagem.
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
AU6289196A (en) A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
WO2008039923A3 (en) Two part antimicrobial boot
BRPI9510423B8 (pt) formulação lipossomal multilamelar de baixa rigidez, e, formulação antiinfecciosa
DE60331849D1 (de) Antibakterielle wirkstoffe
HU0201043D0 (enExample)
ES2129078T3 (es) Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion.
BR9904150A (pt) Composições de proteìnas estabilizadas
BR0213154A (pt) Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos
FI954804A0 (fi) Ioneenipolymeerit matolääkkeinä eläimillä
BR0110382A (pt) Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
WO2000030435A3 (en) Foulbrood treatments
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
WO2002006821A3 (en) Antimicrobial agent
ES2157985T3 (es) Metodo para la prevencion y el tratamiento de la mastitis bovina.
PT1156795E (pt) Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 934075

Country of ref document: ES